TY - JOUR
T1 - The critical role of transmembrane prolines in human prostacyclin receptor activation
AU - Stitham, Jeremiah
AU - Martin, Kathleen A.
AU - Hwa, John
PY - 2002
Y1 - 2002
N2 - The human prostacyclin receptor (hIP), a G protein-coupled receptor (GPCR), plays important roles in vascular smooth muscle relaxation as well as the prevention of platelet aggregation. It has been postulated that GPCR transmembrane (TM) prolines serve as molecular hinges or swivels and are necessary for proper binding and activation. By individually (as well as collectively) mutating these hip prolines to alanine, the ability to form key structural and functional configurations was removed. Significant effects on both binding and activation were observed. Two highly conserved prolines across GPCRs, Pro-154, and Pro-254 (TMVI), showed the greatest effect on decreasing both binding and activation when changed to alanine. Along the extracellular boundary of the highly conserved transmembrane III domain, a proline-to-alanine mutation at position 89 (P89A) revealed normal binding affinity in comparison with the 1D4-epitope-tagged hIp (hIP1D4) wild-type control (Ki, iloprost = 3 ± 2 versus 7 ± 3 nM, respectively). In contrast, activation was markedly affected, with an EC50 of 12.0 ± 2.5 nM compared with that of 1.2 ± 0.3 nM (10-fold difference) for the hIP1D4. Movement within TMIII has been shown to be necessary for effective GPCR activation. Both the extracellular location (above the putative binding pocket) along with an exclusive effect upon activation suggest that this movement is facilitated by the presence of Pro-89 and independent from the actions of ligand binding. This finding strongly supports a model in which proline residues serve as molecular hinges or swivels, essential for coupling receptor binding to activation.
AB - The human prostacyclin receptor (hIP), a G protein-coupled receptor (GPCR), plays important roles in vascular smooth muscle relaxation as well as the prevention of platelet aggregation. It has been postulated that GPCR transmembrane (TM) prolines serve as molecular hinges or swivels and are necessary for proper binding and activation. By individually (as well as collectively) mutating these hip prolines to alanine, the ability to form key structural and functional configurations was removed. Significant effects on both binding and activation were observed. Two highly conserved prolines across GPCRs, Pro-154, and Pro-254 (TMVI), showed the greatest effect on decreasing both binding and activation when changed to alanine. Along the extracellular boundary of the highly conserved transmembrane III domain, a proline-to-alanine mutation at position 89 (P89A) revealed normal binding affinity in comparison with the 1D4-epitope-tagged hIp (hIP1D4) wild-type control (Ki, iloprost = 3 ± 2 versus 7 ± 3 nM, respectively). In contrast, activation was markedly affected, with an EC50 of 12.0 ± 2.5 nM compared with that of 1.2 ± 0.3 nM (10-fold difference) for the hIP1D4. Movement within TMIII has been shown to be necessary for effective GPCR activation. Both the extracellular location (above the putative binding pocket) along with an exclusive effect upon activation suggest that this movement is facilitated by the presence of Pro-89 and independent from the actions of ligand binding. This finding strongly supports a model in which proline residues serve as molecular hinges or swivels, essential for coupling receptor binding to activation.
UR - http://www.scopus.com/inward/record.url?scp=0036235905&partnerID=8YFLogxK
U2 - 10.1124/mol.61.5.1202
DO - 10.1124/mol.61.5.1202
M3 - Article
C2 - 11961139
AN - SCOPUS:0036235905
SN - 0026-895X
VL - 61
SP - 1202
EP - 1210
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 5
ER -